The 2nd General Assembly of SECRETed was held in Reykjavik (Iceland) on 20th – 21th of July 2022. The meeting was hosted by the MATIS partner of SECRETed and focused on the progress achieved during the 1st year of the […]
The 2nd General Assembly of SECRETed was held in Reykjavik (Iceland) on 20th – 21th of July 2022. The meeting was hosted by the MATIS partner of SECRETed and focused on the progress achieved during the 1st year of the […]
The 2nd Newsletter of the SECRETed project has been published! The June issue includes all recent achievements and progress of the SECRETed project. The Newsletter includes: 1. Executive Management Board of SECRETed 2. Overview of SECRETed 3. Methodological steps 4. […]
Professor Nikolas Fokialakis, the leader of the University of Athens partner of SECREted, is in the Organizing Committee of the “70th International Congress and Annual Meeting of the Society for Medicinal Plant and Natural Product Research (GA)”, which will be […]
On 5 May 2022, the end-users of the SECRETed Project – Sphera Encapsulation, PharmaMar, Accuplex Diagnostics and Sylentis – and the project coordinator, IDENER R&D, inaugurated the activities of the WP7 of the SECRETed Project entitled: “Proof of concept for […]
On the 8th of February 2022, the 1st General Assembly meeting of SECRETed project was held remotely due to COVID-19 Pandemic. The General Assembly consists of one representative from each beneficiary participating in the SECRETed project and is chaired by […]
The 1st Press Release of SECRETed project has been published (download it here). The 1st Press Release was motivated by the Kick-off meeting of the SECRETed project and summarizes the objectives of the project and the contribution of all partners to the Work […]
The poster, flyer and roll-up of the SECRETed project have been published and are available for download in the Dissemination Kit. The digital material includes information about: • Overview of SECRETed project• Project Objectives & Impacts• State of The Art• […]
The 1st WP2 Meeting of the SECRETed Project H2020 was held online, in 15th July, with the participation of Matís, PharmaMar, accuplex diagnositcs, Stazione Zoologica Anton Dohrn, Universidad de Sevillal, Lund University and Exelisis! The meeting focused on the specification of […]
SECRETed is a Research and Innovation Action project that has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No. 101000794 in LG-CV-06- 2020 topic: Prospecting aquatic and terrestrial natural biological resources for biologically […]
Sustainable Exploitation of bio-based Compounds Revealed and Engineered from naTural sources Topic: FNR-11-2020 Prospecting aquatic and terrestrial natural biological resources for biologically active compounds
This Project has received funding from the European Community’s H2020 Programme under the grant agreement No. 101000794. The material presented and views expressed here are the responsibility of the author(s) only. Funding Scheme: H2020-FNR-2020-2.
Sustainable Exploitation of bio-based Compounds Revealed and Engineered from naTural sources Topic: FNR-11-2020 Prospecting aquatic and terrestrial natural biological resources for biologically active compounds
This Project has received funding from the European Community’s H2020 Programme under the grant agreement No. 101000794. The material presented and views expressed here are the responsibility of the author(s) only. Funding Scheme: H2020-FNR-2020-2.
Sustainable Exploitation of bio-based Compounds Revealed and Engineered from naTural sources Topic: FNR-11-2020 Prospecting aquatic and terrestrial natural biological resources for biologically active compounds
This Project has received funding from the European Community’s H2020 Programme under the grant agreement No. 101000794. The material presented and views expressed here are the responsibility of the author(s) only. Funding Scheme: H2020-FNR-2020-2.
© Copyright 2026 by EXELISIS IKE
© Copyright 2026 by EXELISIS IKE
